Dycine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 26.48 Cr
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.71 Cr
- Satisfied Charges ₹ 9.50 Cr
- Revenue Growth 3.94%
- Profit Growth -38.54%
- Ebitda 24.90%
- Net Worth 83.08%
- Total Assets 75.41%
About Dycine Pharmaceuticals
Dycine Pharmaceuticals Limited (DPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 July 2010 and has a history of 14 years and six months. Its registered office is in Noida, Uttar Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 26.48 Cr.
The company currently has active open charges totaling ₹30.71 Cr. The company has closed loans amounting to ₹9.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dycine Pharmaceuticals Limited India is Garima Malik as COMPANY SECRETARY. Rupesh Gupta, Alok Singh, and Piyush Singh serve as directors at the Company.
Company Details
- Location Noida, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74992UP2010PLC041545
- Company No.
041545
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Dycine Pharmaceuticals Limited offer?
Dycine Pharmaceuticals Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant.
Who are the key members and board of directors at Dycine Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Garima Malik | Company Secretary | 31-Aug-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Gupta  | Director | 30-Jul-2010 | Current |
| Alok Singh | Director | 30-Jul-2010 | Current |
| Piyush Singh | Director | 30-Jul-2010 | Current |
Financial Performance of Dycine Pharmaceuticals.
Dycine Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.94% increase. The company also saw a substantial fall in profitability, with a 38.54% decrease in profit. The company's net worth Soared by an impressive increase of 83.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dycine Pharmaceuticals?
In 2024, Dycine Pharmaceuticals had a promoter holding of 83.71% and a public holding of 16.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Motoauto Fit Private LimitedPiyush Singh is a mutual person
Charges (Loans)
₹30.71 Cr
₹9.50 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 30.42 Cr
- Others : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Hdfc Bank Limited | ₹29.37 Cr | Open |
| 28 Dec 2021 | Hdfc Bank Limited | ₹5.94 M | Open |
| 02 Nov 2018 | Others | ₹2.88 M | Open |
| 04 Jan 2018 | Hdfc Bank Limited | ₹1.25 M | Open |
| 08 Jun 2017 | Hdfc Bank Limited | ₹3.30 M | Open |
How Many Employees Work at Dycine Pharmaceuticals?
Dycine Pharmaceuticals has a workforce of 248 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dycine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dycine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.